StockIQ.techCVS Health Corporation (CVS) Stock Analysis
Free AI-powered analysis and research for CVS Health Corporation stock
Sector: Healthcare
CVS snapshot
Data as of 3 Nov 2026 close. Updated daily.
CVS Health Corporation scores 32/100 on StockIQ's model, which reads as negative signals overall. The price is above its 200-day average and at 49% of its 52-week range, up 14.4% over the past year. Latest reported figures show a profit margin of 1.2%, return on equity of 6.2% and revenue growth of +7.1%.
What is driving the score
- RSI Neutral: +5
- Downtrend: -4
- MACD Bearish: -8
- Weak Profit Margin (1.2%): -8
- Low Liquidity (0.87 Current Ratio): -10
- Above MA200: +4
- Up Over 1 Year (+14.4%): +3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full CVS report
CVS Health Corporation (CVS) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze CVS Now →📰 Latest Update
CVS Health (CVS) Could Be 27% Undervalued As Earnings Focus Sharpens
Sat, October 31, 2026 at 8:11 AM UTC 3 min read
CVS Health (CVS) is being highlighted as potentially 27% undervalued, as analysts shift their focus toward the company's earnings performance. This assessment is significant for investors, suggesting that CVS may present a buying opportunity if its earnings growth aligns with market expectations. As CVS continues to navigate the evolving healthcare landscape, understanding its valuation could be crucial for making informed investment decisions.